Beyond the Booth: CleanSpace's Live Cleanroom Redefines Engagement

NEW YORK, NY – April 09, 2026 – The era of static tradeshow booths with glossy brochures and conceptual models may be drawing to a close. CleanSpace™, a Pennsylvania-based leader in modular cleanroom construction, has announced plans to erect what it claims is the largest fully operational pharmaceutical cleanroom ever seen on a North American tradeshow floor at the upcoming INTERPHEX Global conference from April 21-23.

This is no mere mock-up. The company will construct a multi-level, fully functioning manufacturing environment on the floor of the Jacob K. Javits Convention Center. The installation is designed to be an immersive experience, allowing attendees to walk through and observe a live, ISO-classified production suite, complete with gowning areas, interconnected modular units, and state-of-the-art processing equipment. The move signals a seismic shift in B2B marketing, transforming the conventional sales pitch into a live, high-stakes demonstration of capability.

A New Blueprint for Experiential Marketing

For decades, tradeshows have been a cornerstone of industry, but attendee engagement has often been limited to passive observation. CleanSpace is betting on a new paradigm, moving from "show and tell" to "show and do." By constructing a working facility, the company is challenging the industry standard and pushing the boundaries of experiential marketing.

The initiative taps into a broader trend where businesses are seeking more authentic and memorable ways to connect with clients. Instead of simply describing their products, companies are creating immersive environments that allow potential customers to see, touch, and understand complex solutions in a real-world context. This approach is particularly potent in highly technical fields like pharmaceuticals, where seeing a system in operation can convey its value far more effectively than any presentation.

The CleanSpace exhibit will stand in stark contrast to traditional displays. It features a multi-level, walkable structure with full-glass observation walls, allowing for uninterrupted views of the processes within. Attendees won't just see a piece of equipment; they will witness an entire workflow, from materials transfer to aseptic fill-finish operations, providing an unparalleled educational opportunity. This live demonstration aims to set a new benchmark for what a tradeshow presence can achieve, offering tangible proof of concept on an unprecedented scale.

The Vertical Integration Advantage on Display

At its core, the ambitious exhibit is a physical manifestation of CleanSpace's business philosophy: vertically integrated project delivery. The company manages every phase of a project in-house—from design and engineering to manufacturing and construction. This model is a direct response to the fragmentation, delays, and cost overruns that can plague complex construction projects in the life sciences sector.

"The industry can't afford fragmented delivery models anymore," a statement from the company's press release noted. "By bringing design, engineering, construction, CQV along with product manufacturing fully in-house, CleanSpace removes uncertainty, accelerates timelines, and ensures compliance with today's modern FDA standards. We're not coordinating vendors; we're delivering certainty."

This philosophy is gaining traction across the specialized construction industry, with competitors like AES Cleanroom Technology and AdvanceTEC also promoting their own "design-build" and "turnkey" solutions. The competitive landscape underscores the industry's demand for providers who can offer a single point of accountability. However, by building a complete, operational facility in a convention center, CleanSpace is making the most audacious statement yet about its ability to execute complex projects with precision and speed. The exhibit is not just a product showcase; it is a live-action case study of their entire business model.

Inside the Live Manufacturing Environment

The centerpiece of the CleanSpace installation is its functionality. The structure is designed as a complete cleanroom suite, featuring multiple interconnected prefabricated modules that form one continuous, compliant environment. This modular approach is a key part of the company's value proposition, enabling rapid deployment of facilities for pharmaceutical and biotech clients who need to get to market quickly.

Inside, attendees will observe a state-of-the-art fill-finish unit from SKAN, a respected Swiss manufacturer of cleanroom and isolator technology. The inclusion of SKAN's equipment is significant, as it demonstrates that CleanSpace's modular architecture can seamlessly integrate sophisticated, third-party processing machinery. It proves the exhibit's credibility as a genuine manufacturing space, not just a well-designed shell.

The experience will be educational, offering a rare, hands-on look at the future of pharmaceutical manufacturing. Visitors can walk through realistic production layouts, observe operational door interlock systems, and see different uPVC wall and ceiling panel options in a real-world application. For industry professionals, facility managers, and even students of pharmaceutical engineering, the exhibit offers a unique chance to bridge the gap between theoretical knowledge and practical application, providing insights that are impossible to glean from a catalog or website.

Setting a New Industry Standard

By investing in such a monumental undertaking, CleanSpace is doing more than just promoting its services; it is attempting to set a new standard for the entire life sciences industry. The exhibit directly addresses the sector's most pressing challenges: the need for speed, regulatory certainty, and efficient, reliable manufacturing capacity.

The live demonstration illustrates exactly how modern modular facilities can accelerate timelines, allowing companies to bring life-saving therapies to patients faster. It showcases how integrated design and construction can ensure compliance with stringent FDA and global regulatory standards from day one, mitigating risk in a high-stakes environment.

This bold move is a testament to the growing importance of modular construction and integrated project delivery in the life sciences. As the industry faces pressure to innovate more rapidly and respond to global health needs, the ability to build and validate compliant manufacturing facilities quickly has become a critical competitive advantage. For three days in April, the future of pharmaceutical facility delivery will not be a concept on a slide, but a living, breathing reality on the floor of the Javits Center.